Research Article

Tissue Expression of Low and High Molecular Weight Cytokeratins in Lung Carcinoma Sections: Its Correlation with Some Clinic-Pathological Features

Table 1

Clinic-pathological characteristics.

FeaturesNSCLC ()SCLC () value
Number of cases (%)Number of cases (%)

Gender
 Female15 (28.8)6 (37.5)0.5460
 Male37 (71.2)10 (62.5)
Age
 <6037 (71.2)13 (81.2)0.5294
 ≥6015 (28.8)3 (18.8)
Tumor size (cm)
 <312 (23.1)7 (43.7)0.1227
 ≥340 (76.9)9 (56.3)
Tumor stage
 Limited disease13 (81.2)
 Extended disease3 (18.8)
 I-IIIA44 (84.6)
 IIIB-IV8 (15.4)
Recurrence
 Yes18 (34.6)11 (68.7)0.0216
 No34 (65.4)5 (31.3)
Lymph node metastasis
 Yes17 (32.7)2 (12.5)0.2012
 No35 (67.3)14 (87.5)
Other site metastases
 Yes5 (9.6)2 (12.5)0.6640
 No47 (90.4)14 (87.5)
Grade of differentiation
 Well/moderate32 (61.5)1 (6.2)0.0001
 Poor/undifferentiated20 (38.5)15 (93.8)
Degree of cell pleomorphism
 Low25 (48.1)7 (43.7)0.7834
 High27 (51.9)9 (56.3)
Necrosis index
 <50%38 (73.1)4 (25.0)0.0009
 ≥50%14 (26.9)12 (75.0)
Mitotic index
 Low24 (46.2)0 (0)0.0006
 High28 (53.8)16 (100)

NSCLC, non-small cell lung carcinoma; SCLC, small cell lung carcinoma; %, percentages.